Anzeige
Mehr »
Login
Freitag, 21.06.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Warum diese Aktie jetzt massiv durchstartet und wie Sie zu neuen Gratis-Aktien kommen…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PWNG | ISIN: US6404422080 | Ticker-Symbol: N18A
Frankfurt
04.01.24
08:03 Uhr
0,115 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEMAURA MEDICAL INC Chart 1 Jahr
5-Tage-Chart
NEMAURA MEDICAL INC 5-Tage-Chart

Aktuelle News zur NEMAURA MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.05.Nemaura Medical Inc. - 8-K, Current Report1
20.04.Nemaura Medical Inc. - 8-K, Current Report1
10.04.Nemaura Medical Inc. - 8-K, Current Report3
21.03.NSE - Nemaura Medical Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities4
20.03.Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival ...216NEW YORK" March 20, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of Latch, Inc. Latch, Inc.'s securities were suspended on August...
► Artikel lesen
26.02.Nemaura Medical Inc. - 8-K, Current Report4
12.02.Nemaura Medical Inc. - 10-Q, Quarterly Report4
05.01.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 05.01.20241.322The following instruments on Boerse Frankfurt do have their last trading day on 05.01.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 05.01.2024ISIN NameIE00BJXRZ273 RIZE-MED.CAN+LSCI.DLA...
► Artikel lesen
05.01.XFRA N18A: AUSSETZUNG/SUSPENSION375DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNEMAURA MED. INC....
► Artikel lesen
03.01.Nemaura Medical, Inc: Important Update on Listing Status and Strategic Direction743Loughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. ("Nemaura Medical" or the "Company"), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs...
► Artikel lesen
03.01.Nemaura Medical Inc. - 8-K, Current Report2
13.12.23Nemaura Medical, Inc: Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision283Loughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) ("Nemaura Medical" or the "Company"), developer of a daily wear non-invasive glucose sensor, and digital healthcare...
► Artikel lesen
14.11.23Nemaura Medical, Inc: Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs1.088Company CEO to discuss development at 1pm EST on 15th November 2023, at the Sidoti Virtual Investor Conference Loughborough, UK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, developer of a...
► Artikel lesen
13.11.23Nemaura Medical, Inc: Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update269Loughborough, England, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing a...
► Artikel lesen
14.09.23Nemaura Medical, Inc: Nemaura Medical Provides Update on Nasdaq Compliance Status and Process340LOUGHBOROUGH, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(Nasdaq: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercialising non-invasive...
► Artikel lesen
14.07.23Nemaura Medical, Inc: Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023323Loughborough, England, July 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing a...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1